Nicole Shea, NP
Family · Dakota Dunes, SDNPI 1174140552
Payments from drug & device makers
What this record shows
19 manufacturers reported payments, led by Abbott at 41.3% of the total. Reporting peaked in 2023 at $2,268 and has fallen 86.1% since, to $315 in 2024. Among family clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 88 payments — averaging $52.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boston Scientific$2K
- AbbVie$408
- Teva Pharmaceuticals USA, Inc.$95
- AstraZeneca$91
- Inspire Medical Systems, Inc.$82
- plus $405 from 13 others
What the payments were for
- Travel & lodging$2,68658%
- Food & beverage$1,93242%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 12 | $1,907 |
| Boston Scientific | 9 | $1,629 |
| AbbVie | 34 | $408 |
| Teva Pharmaceuticals USA, Inc. | 5 | $95 |
| AstraZeneca | 5 | $91 |
| Inspire Medical Systems, Inc. | 1 | $82 |
| Acadia Pharmaceuticals Inc | 3 | $61 |
| Amgen | 2 | $52 |
| Lundbeck LLC | 3 | $51 |
| Amneal Pharmaceuticals LLC | 2 | $41 |
| GE HealthCare | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Pfizer | 2 | $28 |
| Impel Pharmaceuticals Inc. | 1 | $24 |
| CSL Behring | 1 | $18 |
| Biogen | 1 | $17 |
| UCB, Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| SK Life Science, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,618 in reported general payments places this provider in the 95th percentile of 588 family providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aimovig AutoinjectorErenumab-Aooe | 61 | $45,025 |
| RytaryCarbidopa/Levodopa | 38 | $31,941 |
| UbrelvyUbrogepant | 19 | $31,080 |
| Nurtec OdtRimegepant Sulfate | 18 | $27,539 |
| Emgality PenGalcanezumab-Gnlm | 25 | $17,979 |
| Levetiracetam | 209 | $6,861 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 275 | $5,278 |
| Pregabalin | 73 | $3,268 |
| Lacosamide | 20 | $2,242 |
| Gabapentin | 97 | $1,980 |
| Memantine Hcl | 97 | $1,793 |
| Primidone | 115 | $1,628 |
| Lamotrigine | 93 | $1,523 |
| Zonisamide | 36 | $1,471 |
| Donepezil Hcl | 121 | $1,070 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Amneal Pharmaceuticals LLCRytary, Pyridostigmine Bromide | $41 | $32,49452 claims |
| AbbVieUbrelvy | $408 | $31,08019 claims |
| PfizerNurtec Odt | $28 | $27,53918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 588 family providers in South Dakota.
Other family in Dakota Dunes
- Maria AzpeitiaDakota Dunes$8K
- Allison OwingsDakota Dunes$4K
- Carey BaczwaskiDakota Dunes$4K
- Willy GarciaDakota Dunes$3K
- Brooke BuumDakota Dunes$2K
- Chad MillikanDakota Dunes$2K
- Brittany WangsnessSioux Falls$79K
- Stephanie PreisterSioux Falls$12K
- Claudia HouglandRapid City$9K
- Michelle VanhoveSioux Falls$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.